Levothyroxine 200mcg Inj, 1 Vial

Manufacturer FRESENIUS KABI Active Ingredient Levothyroxine Injection Solution(lee voe thye ROKS een) Pronunciation lee voe thye ROKS een
WARNING: Do not use this drug for weight loss. Severe and sometimes deadly side effects may happen with this drug if it is taken in large doses or with other drugs for weight loss. If you have questions, talk with the doctor. @ COMMON USES: It is used to add thyroid hormone to the body.It is used to manage thyroid cancer.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Thyroid hormone
đŸ§Ŧ
Pharmacologic Class
Thyroid hormone replacement
🤰
Pregnancy Category
Category A
✅
FDA Approved
Jan 1955
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Levothyroxine is a medicine that replaces a hormone normally made by your thyroid gland. It's used when your thyroid gland doesn't make enough of this hormone (a condition called hypothyroidism). The injectable form is used when you can't take the medicine by mouth, such as during a severe thyroid emergency or if you're unable to swallow.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all guidelines provided. This drug is administered via intravenous injection.

For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep this medication at home.

If you miss a dose, contact your doctor immediately to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • For IV administration, no specific lifestyle changes are required related to food or other oral intake.
  • Report any new or worsening symptoms to your healthcare provider immediately.
  • Adhere to all monitoring appointments and blood tests as scheduled by your doctor.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For myxedema coma: Initial loading dose of 300-500 mcg IV, followed by 50-100 mcg IV daily. For patients unable to take oral: 50% of the patient's usual oral dose given IV daily.
Dose Range: 50 - 500 mg

Condition-Specific Dosing:

myxedemaComa: Initial loading dose of 300-500 mcg IV, followed by 50-100 mcg IV daily. Consider lower initial dose (100-200 mcg) in patients with known cardiovascular disease.
unableToTakeOral: Approximately 50% of the patient's usual oral levothyroxine dose given IV daily. Adjust based on clinical response and laboratory parameters (TSH, free T4).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for myxedema coma; typically managed with oral therapy. For severe hypothyroidism where oral is not feasible, consult endocrinologist. Doses are highly individualized based on weight and age.
Infant: Not established for myxedema coma; typically managed with oral therapy. For severe hypothyroidism where oral is not feasible, consult endocrinologist. Doses are highly individualized based on weight and age.
Child: Not established for myxedema coma; typically managed with oral therapy. For severe hypothyroidism where oral is not feasible, consult endocrinologist. Doses are highly individualized based on weight and age.
Adolescent: Not established for myxedema coma; typically managed with oral therapy. For severe hypothyroidism where oral is not feasible, consult endocrinologist. Doses are highly individualized based on weight and age.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed.
Moderate: No specific adjustment needed.
Severe: No specific adjustment needed.
Dialysis: No specific adjustment needed; levothyroxine is highly protein-bound and not significantly removed by dialysis.

Hepatic Impairment:

Mild: No specific adjustment needed.
Moderate: No specific adjustment needed.
Severe: No specific adjustment needed, but monitor thyroid function closely as hepatic metabolism may be altered in severe liver disease.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Levothyroxine (T4) is a synthetic form of the natural thyroid hormone, thyroxine. It is converted to its active metabolite, liothyronine (T3), in peripheral tissues. T3 then binds to thyroid hormone receptors in the cell nucleus, regulating gene expression and controlling numerous metabolic processes, including protein, carbohydrate, and lipid metabolism, and influencing growth and development.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (for IV administration)
Tmax: Not applicable (IV administration)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 10-13 L
ProteinBinding: Greater than 99% (primarily to thyroxine-binding globulin (TBG), transthyretin (TTR), and albumin)
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 6-7 days (euthyroid individuals); can be shorter in hyperthyroidism (3-4 days) and longer in hypothyroidism (9-10 days).
Clearance: Approximately 0.05 L/hr
ExcretionRoute: Renal (approximately 80% of metabolites), fecal (approximately 20% of metabolites and unabsorbed drug)
Unchanged: Less than 1% (excreted unchanged)
âąī¸

Pharmacodynamics

OnsetOfAction: Clinical effects of IV administration may be observed within hours to days, but full therapeutic effect may take several weeks due to the long half-life and need for tissue saturation.
PeakEffect: Peak therapeutic effect is typically observed weeks after initiation or dose adjustment.
DurationOfAction: Due to its long half-life, effects persist for several days after discontinuation.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Chest pain or pressure
Fast or abnormal heartbeat
Shortness of breath
Sudden weight gain or swelling in the arms or legs
Headache
Feeling tired or weak
Changes in appetite
Unintentional weight changes
Diarrhea, stomach cramps, or vomiting
Mood changes, such as feeling irritable, nervous, excitable, anxious, or restless
Shakiness
Trouble sleeping
Sensitivity to heat
Excessive sweating
Fever
Muscle cramps
Muscle weakness
Flushing
Bone pain
Changes in menstrual periods (in women)
In children: hip or knee pain, or a limp
In infants: changes in the shape of the head and face

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

* Hair loss (usually temporary and resolves on its own within the first few months of treatment)

Reporting Side Effects

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Chest pain
  • Palpitations or rapid heart rate
  • Shortness of breath
  • Excessive sweating
  • Tremors
  • Nervousness or anxiety
  • Insomnia
  • Unexplained weight loss
  • Severe headache
  • Seizures
  • Signs of adrenal crisis (severe weakness, dizziness, confusion, abdominal pain)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ An overactive thyroid gland
+ A weak adrenal gland

This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor.

To ensure your safety, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
* Your health problems, both past and present

Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe to do so. This will help prevent potential interactions and ensure the safe use of this medication.
âš ī¸

Precautions & Cautions

Important Information for All Patients Taking This Medication

It is crucial that you inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. To ensure uninterrupted treatment, do not allow your supply of this medication to run out. You may not experience the full effects of this medication for several weeks.

If you have diabetes (high blood sugar), consult with your doctor, as this medication may affect your blood sugar control. Your doctor may need to adjust your diabetes medications. Be sure to monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as recommended.

If you are taking biotin or a product containing biotin, stop taking it at least 2 days before having your thyroid levels checked to ensure accurate test results.

Potential Risks and Side Effects

High doses of this medication may increase the risk of developing weak bones (osteoporosis), particularly after menopause. Discuss your risk factors with your doctor, who can help determine if you are at higher risk or answer any questions you may have.

This medication may also affect fertility, potentially making it difficult to become pregnant or father a child. If you plan to conceive, consult with your doctor before starting this medication.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor, who will discuss the benefits and risks of this medication for both you and your baby.

Pediatric Patients

If your child is taking this medication and experiences any changes in weight, consult with your doctor, as the dosage may need to be adjusted. Never give your child more of this medication than prescribed, as this can increase the risk of severe side effects.

In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so be sure to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Palpitations
  • Tachycardia
  • Arrhythmias
  • Chest pain
  • Tremors
  • Nervousness
  • Insomnia
  • Excessive sweating
  • Heat intolerance
  • Weight loss
  • Diarrhea
  • Vomiting
  • Fever
  • Seizures (rare)
  • Coma (rare)

What to Do:

Seek immediate medical attention. Management is symptomatic and supportive. May involve reducing absorption (if oral overdose), beta-blockers for cardiac symptoms, and other supportive care. Call 1-800-222-1222 for poison control.

Drug Interactions

🔴

Major Interactions

  • Amiodarone (can cause hypo- or hyperthyroidism, alters T4 to T3 conversion)
  • Antacids (aluminum, magnesium, calcium) - for oral form, but relevant if patient transitions to oral
  • Iron supplements - for oral form, but relevant if patient transitions to oral
  • Sucralfate - for oral form, but relevant if patient transitions to oral
  • Bile acid sequestrants (cholestyramine, colestipol) - for oral form, but relevant if patient transitions to oral
  • Proton pump inhibitors (e.g., omeprazole) - for oral form, may reduce absorption
  • Certain anticonvulsants (e.g., carbamazepine, phenytoin, phenobarbital) - may increase levothyroxine metabolism
  • Rifampin - may increase levothyroxine metabolism
  • Sertraline - may increase levothyroxine requirements
  • Tyrosine kinase inhibitors (e.g., imatinib, sunitinib) - may increase levothyroxine requirements
🟡

Moderate Interactions

  • Oral anticoagulants (e.g., warfarin) - levothyroxine may enhance anticoagulant effect, requiring dose reduction of anticoagulant
  • Beta-blockers (e.g., propranolol) - may reduce conversion of T4 to T3
  • Tricyclic antidepressants (e.g., amitriptyline) - increased risk of cardiac arrhythmias and CNS excitation
  • Insulin and oral hypoglycemics - levothyroxine may increase blood glucose, requiring adjustment of antidiabetic agents
  • Digitalis glycosides (e.g., digoxin) - levothyroxine may decrease digoxin levels or effect
  • Estrogens (oral) - may increase TBG, increasing levothyroxine requirements
  • Androgens - may decrease TBG, decreasing levothyroxine requirements
đŸŸĸ

Minor Interactions

  • Dietary fiber - for oral form, may reduce absorption
  • Soy products - for oral form, may reduce absorption

Monitoring

đŸ”Ŧ

Baseline Monitoring

Thyroid Stimulating Hormone (TSH)

Rationale: To assess baseline thyroid function and confirm diagnosis of hypothyroidism.

Timing: Prior to initiation of therapy.

Free Thyroxine (Free T4)

Rationale: To assess baseline thyroid function and confirm diagnosis of hypothyroidism, especially in central hypothyroidism or myxedema coma.

Timing: Prior to initiation of therapy.

Cardiac status (ECG, vital signs)

Rationale: To assess for underlying cardiovascular disease, especially important in myxedema coma due to risk of cardiac complications with rapid thyroid hormone replacement.

Timing: Prior to initiation and during initial treatment, particularly with IV loading doses.

Adrenal function (e.g., cortisol levels)

Rationale: To rule out co-existing adrenal insufficiency, which must be treated with glucocorticoids before or concurrently with levothyroxine to avoid adrenal crisis.

Timing: Prior to initiation in patients with suspected myxedema coma or long-standing hypothyroidism.

📊

Routine Monitoring

Thyroid Stimulating Hormone (TSH)

Frequency: Every 4-6 weeks after initiation or dose change, then every 6-12 months once stable.

Target: 0.4-4.0 mIU/L (individualized based on patient age, comorbidities, and specific condition).

Action Threshold: Adjust dose if TSH is outside target range; higher TSH indicates under-replacement, lower TSH indicates over-replacement.

Free Thyroxine (Free T4)

Frequency: Every 4-6 weeks after initiation or dose change, then every 6-12 months once stable, or if TSH is suppressed/elevated.

Target: 0.8-1.8 ng/dL (or within upper half of reference range for primary hypothyroidism).

Action Threshold: Adjust dose if Free T4 is outside target range, especially in central hypothyroidism or when TSH is unreliable.

Clinical symptoms (e.g., fatigue, weight changes, cold intolerance, heart rate)

Frequency: Continuously, at each clinical visit.

Target: Resolution of hypothyroid symptoms, absence of hyperthyroid symptoms.

Action Threshold: Evaluate for dose adjustment or other causes if symptoms persist or new symptoms develop.

Vital signs (heart rate, blood pressure)

Frequency: Daily or more frequently in acute settings (e.g., myxedema coma), then at each clinical visit.

Target: Within normal limits for the patient.

Action Threshold: Tachycardia, palpitations, or hypertension may indicate over-replacement; bradycardia or hypotension may indicate under-replacement or other issues.

đŸ‘ī¸

Symptom Monitoring

  • Fatigue
  • Weight gain or loss
  • Cold or heat intolerance
  • Constipation or diarrhea
  • Dry skin
  • Hair loss
  • Muscle aches or weakness
  • Depression or anxiety
  • Memory problems
  • Bradycardia or tachycardia
  • Palpitations
  • Tremors
  • Nervousness
  • Insomnia

Special Patient Groups

🤰

Pregnancy

Levothyroxine is considered safe and essential during pregnancy. Thyroid hormone requirements often increase during pregnancy, necessitating dose adjustments.

Trimester-Specific Risks:

First Trimester: Untreated hypothyroidism in the first trimester is associated with increased risk of miscarriage, preterm birth, and impaired neurocognitive development in the fetus. Dose adjustments are often needed early in pregnancy.
Second Trimester: Continued monitoring and dose adjustments are crucial to maintain euthyroid state.
Third Trimester: Continued monitoring and dose adjustments are crucial to maintain euthyroid state. Dose may need to be increased further.
🤱

Lactation

Levothyroxine is compatible with breastfeeding. Only small amounts are excreted into breast milk, which are not considered harmful to the infant.

Infant Risk: L1 (Safest) - No known risk to the infant.
đŸ‘ļ

Pediatric Use

Dosing is highly individualized based on age, weight, and severity of hypothyroidism. Close monitoring of TSH and Free T4 is essential. IV formulation is generally reserved for severe cases (e.g., myxedema coma) or when oral administration is not possible. Over-treatment can lead to craniosynostosis in infants and accelerated bone maturation in children.

👴

Geriatric Use

Lower initial doses are generally recommended due to increased sensitivity to thyroid hormones and higher prevalence of underlying cardiovascular disease. Dose titration should be gradual and cautious, with close monitoring for cardiac side effects.

Clinical Information

💎

Clinical Pearls

  • IV levothyroxine is primarily used for myxedema coma or when oral administration is not feasible (e.g., NPO status, severe malabsorption).
  • For myxedema coma, a large loading dose is typically given, followed by daily maintenance doses. Consider lower loading doses in patients with known cardiac disease.
  • Always rule out or treat adrenal insufficiency with glucocorticoids before or concurrently with levothyroxine in patients with suspected myxedema coma to prevent adrenal crisis.
  • The IV dose is typically 50% of the patient's usual oral dose when converting from oral to IV due to 100% bioavailability of the IV form.
  • Monitor cardiac status closely, especially during the initial phase of treatment for myxedema coma, due to the risk of arrhythmias and myocardial ischemia.
  • Thyroid function tests (TSH, Free T4) should be monitored regularly to guide dose adjustments, though TSH response may be delayed due to the long half-life.
🔄

Alternative Therapies

  • Liothyronine (T3) injection (for rapid onset in severe cases, often used in combination with levothyroxine for myxedema coma)
  • Desiccated thyroid extract (contains T4 and T3, not available in injectable form)
💰

Cost & Coverage

Average Cost: Varies widely, typically $50-$200+ per 1 vial (200mcg)
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic), Tier 2 or 3 (brand)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed otherwise, do not flush medications down the toilet or drain. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time of the incident.